ALID Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume500.00
Average Volume (3M)488.00
Market Cap
$115.00
Enterprise Value$5.71M
Total Cash (Recent Filing)$209.74K
Total Debt (Recent Filing)$5.86M
Price to Earnings (P/E)―
Beta915.02
Next Earnings
Jan 19, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding115,495,384
10 Day Avg. Volume413
30 Day Avg. Volume488
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)-3.30
Price to Sales (P/S)315.52
P/FCF Ratio-11.13
Enterprise Value/Market Cap49.65K
Enterprise Value/Revenue79.19
Enterprise Value/Gross Profit-3.81
Enterprise Value/Ebitda-0.76
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Allied (California) News
ALID FAQ
What was Allied Corp (California)’s price range in the past 12 months?
Allied Corp (California) lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Allied Corp (California)’s market cap?
Allied Corp (California)’s market cap is $115.00.
When is Allied Corp (California)’s upcoming earnings report date?
Allied Corp (California)’s upcoming earnings report date is Jan 19, 2027 which is in 143 days.
How were Allied Corp (California)’s earnings last quarter?
Currently, no data Available
Is Allied Corp (California) overvalued?
According to Wall Street analysts Allied Corp (California)’s price is currently Overvalued.
Does Allied Corp (California) pay dividends?
Allied Corp (California) does not currently pay dividends.
What is Allied Corp (California)’s EPS estimate?
Allied Corp (California)’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Allied Corp (California) have?
Allied Corp (California) has 115,495,384 shares outstanding.
What happened to Allied Corp (California)’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Allied Corp (California)?
Currently, no hedge funds are holding shares in ALID
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Allied Corp (California)
Allied Corp. (ALID) specializes in the research, development, and production of cannabinoid health solutions, primarily operating in the United States. The company markets a diverse portfolio of natural health products derived from hemp under various brands. Its "Tactical Relief" line features items such as Liberty, a CBD tincture; Tactical Hydration, a CBD-infused electrolyte beverage; FIZZ Tablets designed for water bottles; Battle Balm, a CBD roll-on formulated for activity-related aches and pains; and Quick Hit, a CBD gummy. Similarly, the "Equilibrium Bio" brand encompasses Hydrosport CBD Drink, an electrolyte beverage fortified with sodium citrate; Hydrosport Tincture, a CBD tincture enhanced with specific terpene profiles; FIZZ Tablets for customizable drinks; Sport Rub, a CBD topical for post-activity muscle relief; and Quick Hit, a CBD gummy enriched with vitamin B12. Additionally, Allied Corp. distributes a specialized skincare line under its "MaXXa" brand. This collection features Skin Structure, a facial formula for enhancing skin radiance and youthfulness; Eye Recover, designed to protect delicate eye skin from free radicals and sun damage; Glossy Lip Recover, which moisturizes and nourishes lips; Skin Designer, stimulating cell regeneration and minimizing age spots; Vitamin Absolute, a hydrating facial oil; and Absolute Recover, a formulation for direct delivery of bioactive compounds to address inflammation, pain, and other skin ailments. Beyond its consumer product portfolio, Allied Corp. is also engaged in pharmaceutical development, with ALID 10 and ALID 11, experimental drug candidates, currently in Phase I clinical trials for the treatment of post-traumatic stress disorder (PTSD). Established in 2013, Allied Corp. maintains its corporate headquarters in Kelowna, Canada.
Technical Analysis
China Pharma Holdings
―
Sonoma Pharmaceuticals
―
―
PainReform
―
Shuttle Pharmaceuticals Holdings, Inc.
―
